Huber Martin H. Jr.
President, CEO at Mersana Therapeutics, Inc.; SVP & Chief Medical Officer at TESARO, Inc.
- Sold, on record
- $850k
- Dollars the filings state
- Form 4 sales
- 12
- Latest Sep 12, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Mersana Therapeutics, Inc.President, CEO
- TESARO, Inc.SVP & Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Mersana Therapeutics, Inc.56,949 shares
- TESARO, Inc.6,777 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TESARO, Inc.Plan not statedSep 22, 2017 2017
Sold 592 shares at $118.60 ($70k)
Huber Martin H. Jr., SVP & Chief Medical Officer
Sold 8.5% of holdings ($823k position)6,351 shares left1.5x usual sizeFiling
- 2 Form 4 sale TESARO, Inc.Plan not statedDec 4, 2017 +73 days
Sold 829 shares at $85.24 ($71k)
Huber Martin H. Jr., SVP & Chief Medical Officer
Sold 10.2% of holdings ($691k position)7,272 shares left1.7x usual sizeFiling
- 3 Form 4 sale TESARO, Inc.UnusualMar 2, 2018 +88 days
Sold 1,803 shares at $54.86 ($99k)
Huber Martin H. Jr., SVP & Chief Medical Officer
Sold 13.7% of holdings ($720k position)11,327 shares left3x usual sizeFiling
- 4 Form 4 sale TESARO, Inc.Plan not statedSep 24, 2018 +206 days
Sold 371 shares at $37.63 ($14k)
Huber Martin H. Jr., SVP & Chief Medical Officer
Sold 2.9% of holdings ($473k position)12,206 shares left0.4x usual sizeFiling
- 5 Form 4 sale Mersana Therapeutics, Inc.RoutineSep 12, 2024 +2180 days
Sold 50,423 shares at $1.76 ($89k)
Huber Martin H. Jr., President, CEO
10b5-1 planSold 30.2% of holdings ($293k position)116,327 shares leftFirst sale on recordFiling
- 6 Form 144 notice Mersana Therapeutics, Inc.NoticeSep 13, 2024 +1 day
Filed to sell 50,423 shares ($89k)
Huber Martin H. Jr., Officer, Director
10b5-1 planFiling
- 7 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2025 +125 days
Sold 4,514 shares at $0.58 ($3k)
Huber Martin H. Jr., President, CEO
10b5-1 planSold 3.5% of holdings ($74k position)122,875 shares leftFiling
- 8 Form 4 sale Mersana Therapeutics, Inc.RoutineSep 12, 2025 +239 days
Sold 2,012 shares at $7.31 ($15k)
Huber Martin H. Jr., President, CEO
10b5-1 planSold 17.4% of holdings ($85k position)9,572 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Sep 15, 2025 | Mersana Therapeutics, Inc. | President, CEO | Form 4 sale | 2,012 | $15k | 17.4% | Routine | SEC |
| Jan 16, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | President, CEO | Form 4 sale | 4,514 | $3k | 3.5% | Routine | SEC |
| Sep 13, 2024 | Sep 13, 2024 | Mersana Therapeutics, Inc. | Officer, Director | Form 144 notice | 50,423 | $89k | Notice | SEC | |
| Sep 12, 2024 | Sep 13, 2024 | Mersana Therapeutics, Inc. | President, CEO | Form 4 sale | 50,423 | $89k | 30.2% | Routine | SEC |
| Sep 24, 2018 | Sep 25, 2018 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 371 | $14k | 2.9% | Plan not stated | SEC |
| Mar 2, 2018 | Mar 5, 2018 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 1,803 | $99k | 13.7% | Unusual | SEC |
| Dec 4, 2017 | Dec 5, 2017 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 829 | $71k | 10.2% | Plan not stated | SEC |
| Sep 22, 2017 | Sep 25, 2017 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 592 | $70k | 8.5% | Plan not stated | SEC |
| Apr 3, 2017 | Apr 4, 2017 | TESARO, Inc. | SVP & Cheif Medical Officer | Form 4 sale | 829 | $127k | 12.7% | Plan not stated | SEC |
| Mar 2, 2017 | Mar 3, 2017 | TESARO, Inc. | Sr. VP, Chief Medical Officer | Form 4 sale | 1,428 | $254k | 23.0% | Unusual | SEC |
| Jan 3, 2017 | Jan 3, 2017 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 190 | $26k | Plan not stated | SEC | |
| Nov 2, 2016 | Nov 3, 2016 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 327 | $40k | 17.8% | Plan not stated | SEC |
| Sep 22, 2016 | Sep 23, 2016 | TESARO, Inc. | SVP & Chief Medical Officer | Form 4 sale | 408 | $44k | 32.6% | Unusual | SEC |